WithdrawnPhase 2NCT01925001

Phase 2 Study of MP4CO to Treat Vaso-occlusive Sickle Crisis

Studying Sickle cell anemia

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Sangart
Principal Investigator
Tania Small, MD
Sangart, Inc., San Diego, CA
Intervention
MP4CO(drug)
Eligibility
16 years · All sexes
Timeline
2013 – 2015

Study locations (14)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT01925001 on ClinicalTrials.gov

Other trials for Sickle cell anemia

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell anemia →

← Back to all trials